Безопасность и риск фармакотерапии (Feb 2018)
Recommendations for evaluating the safety of medicinal products containing nanoparticles
Abstract
Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.